elucidated a novel mechanism whereby SIRT3‐dependent GOT2 acetylation affects the malate–aspartate NADH shuttle activity and promotes pancreatic tumor growth (Yang et al., 2015). The gene discussed is GOT2; the disease is pancreatic neoplasm.